HOUSE 2428116th CongressReferred to the Subcommittee on Health.
Access to Breast Cancer Diagnosis Act of 2019
- Last Action
- 5/2/2019
Actions
- 2019-05-02Referred to the Subcommittee on Health.
- 2019-05-01Referred to the House Committee on Energy and Commerce.
- 2019-05-01Introduced in House
- 2019-05-01Introduced in House
CRS Summary
As of 2019-05-01 (00)
Access to Breast Cancer Diagnosis Act of 2019
This bill prohibits private health insurance plans from imposing higher cost-sharing requirements on breast cancer diagnostic examinations than initial breast cancer screening examinations. Diagnostic examinations are generally required after an initial screening detects an abnormality and typically require additional mammogram images (e.g., x-rays).
Cosponsors (20)
- PETER KING (R-NY)
- Debbie Wasserman Schultz (D-FL)
- Brian Fitzpatrick (R-PA)
- Colin Allred (D-TX)
- Cathy Rodgers (R-WA)
- Joaquin Castro (D-TX)
- ELEANOR NORTON (D-DC)
- Susan Wild (D-PA)
- Yvette Clarke (D-NY)
- SHEILA JACKSON LEE (D-TX)
- Andy Kim (D-NJ)
- Ann Kuster (D-NH)
- Al Green (D-TX)
- Katie Porter (D-CA)
- Matt Cartwright (D-PA)
- Lisa Blunt Rochester (D-DE)
- SUSAN DAVIS (D-CA)
- James Himes (D-CT)
- Steve Cohen (D-TN)
- Scott Tipton (R-CO)
Subjects
- Cancer
- Health care costs and insurance
- Health care coverage and access
- Health care quality
- Health promotion and preventive care
- Medical tests and diagnostic methods
- Women's health
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.